Formulation development in the Bioraza laboratory

CDMO services

Formulation Development

Complex oral solid dosage forms, developed with more than one technology solution for every challenge.

Overview

From difficult molecule to robust, scalable formulation

Our formulation development group focuses on immediate and controlled release oral solids that are complex in nature and present competitive barriers to entry. The breadth of our technology platforms means we can offer more than one solution to any drug formulation challenge.

Development programmes are supported by in-house analytical method development, stability studies and regulatory expertise, so that what works in the laboratory is ready for commercial scale.

  • Feasibility assessment and prototype screening
  • Robust, scalable processes designed for commercial manufacture
  • Stability studies and analytical validation
  • Full documentation for regulatory submission
Gloved hands operating a microscope during formulation analysis

Platforms

We recommend the following

Immediate Release Dosage Forms

Conventional tablets and capsules with rapid, reliable dissolution.

Bioavailability Enhancement

Technologies that improve absorption for poorly soluble actives.

Orally Disintegrating Tablets

Fast-dispersing tablets for patients who struggle with swallowing.

Taste Masking

Palatable formulations for sensitive or bitter active ingredients.

Controlled Release Technologies

Precise release profiles tailored to clinical need.

Sustained Release

Release engineered over 8 to 24 hours for once- or twice-daily dosing.

Zero Order Release

Constant drug release rates independent of time.

Delayed Release

Enteric and site-specific release for targeted delivery.

Pulsatile Release

Programmed, time-controlled multi-dose release.

Chrono Release

Release aligned to the body's circadian rhythms.

How we work

A disciplined development pathway

Brief & feasibility

We review your molecule, target product profile and regulatory strategy, then confirm feasibility and risks.

Prototype development

Screening trials identify the formulation platform and prototype that best meets the target profile.

Analytical development

Methods are developed and validated, with stability programmes designed around your submission plan.

Scale-up & exhibit batches

Processes are transferred to our cGMP facility for scale-up, exhibit and registration batches.

Regulatory support

Complete development and manufacturing documentation supports your filing and inspection needs.

Start a programme

Challenge us with your formulation

Send us your molecule and target product profile — we will respond with a development route and timeline.